[Summary text]
Study design: Randomized controlled trial
Study grouping: Parallel group
Open Label: YES
Baseline Characteristics
Individualized written home management plan (Intervention group = Group A)
No individualized written home management plan (Control group= Group B)
Intervention Characteristics
Individualized written home management plan (Intervention group = Group A)
No individualized written home management plan (Control group= Group B)
Continuous:
Country: India
Study design: Randomized controlled trial
Study grouping: Parallel group
Baseline Characteristics
Individualized written home management plan (Intervention group = Group A)
No individualized written home management plan (Control group= Group B)
Included criteria: Childrenagedbetween3and16years,who required admission for their asthma or attended the paediatric outpatients department were eligible for the study
Excluded criteria: Not specified
Intervention Characteristics
Individualized written home management plan (Intervention group = Group A)
No individualized written home management plan (Control group= Group B)
Continuous:
Sponsorship source: 3M Healthcare, Wessex Regional Health Authority, Wessex Medical School Trust, Astra Pharmaceuticals, Boehringer Ingleheim, Allan and Hanburys, Fison's Pharmaceuticals
Country: Australia
Setting: Pediatric department
Comments: None
Authors name: Ian Charlton
Institution: University of Southampton, Department of Paediatrics
Email: none
Address: Tilba Street, Kincumber, 2251, NSW, Australia
Baseline characteristics:
Bo Chawes No SD given
Continuous outcomes:
Bo Chawes mean = median. IQR for de enkelte rækker er:2.3 (0-4.9) 0.15 (0.06-0.43)0.26 (0.85-0.47)0.06 (0.03-0.2)1.9 (0.7-3.2)2.1 (0-6.9)2.0 (0.5-5.3)0.25 (0.1-0.7)0.22 (0.18-0.65)0.13 (0.04-0.4)1.7 (0.8-3.5)4.7 (0-10)
Study design: Randomized controlled trial
Study grouping: Parallel group
Baseline Characteristics
Intervention: Written Asthma Plan with prescription (WAP-P)
Control: Unformatted prescription (UP)
Intervention Characteristics
Intervention: Written Asthma Plan with prescription (WAP-P)
Control: Unformatted prescription (UP)
Continuous:
Country: Canada
Authors name: Francine M. Ducharme
Email: francine.m.ducharme@umontreal.ca
Continuous outcomes:
June Kehlet Marthin Quality of Life:As measured by the validated 23-item Pediatric Asthma Quality of Life Questionnaire on a scale of 1 (worst) to 7 (best) (35).Note: In Table with Fluticasone adherence and CI: MEDIAN values in % are given for Fluticasone data 0-14 and 15-28 days- NOT mean. Lower CL=25% NOT 5%, upper CI 75% NOT 95%In same table given number (%) for asthma control data, OCS data and Qol data
Study design: Randomized controlled trial
Study grouping: Parallel group
Open Label: YES
Baseline Characteristics
Intervention: Written Asthma Action Plan (WAAP) +standard care including edcucation
Control: No WAAP. Only standard care including education
Included criteria: Children with partly controlled asthma and a history of presenting to the ER within past 6 months for acute treatment of bronchospasm.Ability of child/parent to follow written directions
Excluded criteria: uncontrolled astmaticsco-morbid respiratory illnesschild/parents not able to follow written directionschild already in poessesion of WAAPchild treated outside Chaguanaprevious enrollment in asthma education programme
Intervention Characteristics
Intervention: Written Asthma Action Plan (WAAP) +standard care including edcucation
Control: No WAAP. Only standard care including education
Continuous:
Sponsorship source: self funded
Country: Trinidad, West Indies
Setting: Faculty of Medical sciences
Comments: none
Authors name: Raveed Khan
Institution: Faculty of Medical sciences. Dept of public health and primary care
Email: raveed01@hotmail.com
Address: University of the West Indies, St. Augustine, Trinidad
Study design: Randomized controlled trial
Study grouping: Parallel group
Open Label: YES
Baseline Characteristics
Individualized written home management plan (Intervention group = Group A)
No individualized written home management plan (Control group= Group B)
Included criteria: Children eligible for inclusion in the study were aged 18 months to 5 years inclusive at the time of admission to a children’s ward or attendance at either an accident and emergency (A&E) department or the children’s (emergency) assessment unit (CAU at LRI) with a primary diagnosis of acute severe asthma or wheezing
Excluded criteria: Not all eligible children admitted as inpatients during the study period were included as recruitment did not take place over weekends or when a specialist respiratory nurse was not available
Intervention Characteristics
Individualized written home management plan (Intervention group = Group A)
No individualized written home management plan (Control group= Group B)
Continuous:
Dichotomous:
Sponsorship source: NHS Executive Mother and Child Health Programme (MCH 16-15)
Country: UK
Setting: Pediatric asthma clinic
Comments: none
Authors name: C A Stevens
Institution: Leicester Children’s Asthma Centre, University of Leicester
Email: ms70@le.ac.uk
Address: eicester Children’s Asthma Centre, University of Leicester, Leicester LE2 7LX, UK
Baseline characteristics:
Bo Chawes median age (range) in months
Intervention characteristics:
Bo Chawes follow-up 3, 6 and 12mo. But no follow-up after the intervention was finalized.
Dichotomous outcomes:
Bo Chawes n = median. For de fire rækker er range:3 (0-16)3 (0-12)3 (0-16)2 (0-12)
Study design: Randomized controlled trial
Study grouping: Parallel group
Open Label: YES
Baseline Characteristics
Intervention: Symptom-based Written Asthma Action Plan (WAAP)
Control: No WAAP.
Included criteria: Children with confirmed asthma and on regular follow up
Excluded criteria: not described
Intervention Characteristics
Intervention: Symptom-based Written Asthma Action Plan (WAAP)
Control: No WAAP.
Continuous:
Sponsorship source: som Bo
Country: Malaysia
Comments: none
Authors name: Su Sian Wong
Institution: Dept of Pediatrics, university Malaya Medical Centre
Email: psr9900@hotmal.com
Address: Lembah Pantar, 59100, Kuala Lumpur, malaysia
Pretreatment:
Bo Chawes Kun angivet deskriptivt i tabel 1 og 2 og slet ikke kommenteret eller lavet statistiske analyser. ETS er dobbelt så hyppigt i kontrol gruppen, forskellig kønsratio. Flere børn i interventions grp. som har oplevet ED besøg før studiet, hvilket kunne påvirke primary endpoint analyse.
Wrong comparator
Wrong comparator
Adult population
Adult population
Adult population
Wrong study design
Adult population
Adult population
Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence
Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment
Unclear
Unclear
Performance bias due to knowledge of the allocated interventions by participants and personnel during the study
Detection bias due to knowledge of the allocated interventions by outcome assessors
Unclear
Unclear
Attrition bias due to amount, nature or handling of incomplete outcome data
Reporting bias due to selective outcome reporting
Bias due to problems not covered elsewhere in the table
Unclear
Comment: Mange metodologiske problemer bla skævhed i astma sværhedsgrad ved baseline; køn; tobakseposure; uklart om håndtering af kliniske kontroller og analyser er blndet.